• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海马体保护全脑放疗对脑转移瘤患者生存和认知功能的影响。

The Impact of Hippocampal-Sparing Whole-Brain Radiotherapy on Survival and Cognitive Function in Patients with Brain Metastases.

出版信息

Altern Ther Health Med. 2024 Jan;30(1):111-115.

PMID:37773653
Abstract

OBJECTIVE

To explore the effects on cognitive function and survival time of whole-brain intensity-modulated radiotherapy using radiotherapy equipment to protect the hippocampus.

METHODS

Thirty-six patients with brain metastases treated at Qianjiang Central Hospital were enrolled in this study from January 2019 to September 2022. The patients were randomly divided into 2 groups: 15 patients received hippocampal-protection whole-brain radiotherapy, and 21 patients received conventional whole-brain radiotherapy. The Montreal Cognitive Assessment was used to evaluate the cognitive function of patients before and 24 hours, 2 months, 6 months, and 12 months after radiotherapy. Cognitive dysfunction and survival time were compared between the 2 groups.

RESULTS

The overall mean differences in the Montreal Cognitive Assessment scores between the hippocampal-protection group and the conventional whole-brain radiotherapy group were statistically significant at 6 months (P = .006) and 12 months (P = .04) after radiotherapy. The median overall survival was 16 months (95% CI, 11.54-20.46) for the hippocampal-protection group and 14 months (95% CI, 12.9-15.21) for the conventional whole-brain radiotherapy group (P = .578). The median progression-free survival was 12 months (95% CI, 9.74-14.26) for the hippocampal-protection group and 9 months (95% CI, 6.60-11.44) for the conventional whole-brain radiotherapy group (P = .494).

CONCLUSION

Whole-brain radiotherapy for protecting the hippocampus can delay cognitive dysfunction in patients to some extent.

摘要

目的

探索使用放射治疗设备保护海马的全脑强度调节放射治疗对认知功能和生存时间的影响。

方法

本研究纳入 2019 年 1 月至 2022 年 9 月在潜江中心医院接受治疗的 36 例脑转移患者。将患者随机分为 2 组:15 例患者接受海马保护全脑放疗,21 例患者接受常规全脑放疗。使用蒙特利尔认知评估量表评估患者放疗前和放疗后 24 小时、2 个月、6 个月和 12 个月的认知功能。比较两组患者的认知功能障碍和生存时间。

结果

海马保护组和常规全脑放疗组患者在放疗后 6 个月(P =.006)和 12 个月(P =.04)时蒙特利尔认知评估量表评分的总体平均差异具有统计学意义。海马保护组的中位总生存期为 16 个月(95%CI,11.54-20.46),常规全脑放疗组为 14 个月(95%CI,12.9-15.21)(P =.578)。海马保护组的中位无进展生存期为 12 个月(95%CI,9.74-14.26),常规全脑放疗组为 9 个月(95%CI,6.60-11.44)(P =.494)。

结论

保护海马的全脑放疗在一定程度上可以延缓患者的认知功能障碍。

相似文献

1
The Impact of Hippocampal-Sparing Whole-Brain Radiotherapy on Survival and Cognitive Function in Patients with Brain Metastases.海马体保护全脑放疗对脑转移瘤患者生存和认知功能的影响。
Altern Ther Health Med. 2024 Jan;30(1):111-115.
2
Preventive Effect of Hippocampal Sparing on Cognitive Dysfunction of Patients Undergoing Whole-Brain Radiotherapy and Imaging Assessment of Hippocampal Volume Changes.海马体保留对全脑放疗患者认知功能障碍的预防作用及海马体体积变化的影像学评估
Biomed Res Int. 2022 Apr 5;2022:4267673. doi: 10.1155/2022/4267673. eCollection 2022.
3
Estimating the probability of underdosing microscopic brain metastases with hippocampal-sparing whole-brain radiation.评估采用保留海马的全脑放疗对微小脑转移灶剂量不足的概率。
Radiother Oncol. 2016 Aug;120(2):248-52. doi: 10.1016/j.radonc.2016.05.030. Epub 2016 Jul 9.
4
The Effect of Hippocampal Avoidance Whole Brain Radiotherapy on the Preservation of Long-Term Neurocognitive Function in Non-Small Cell Lung Cancer Patients With Brain Metastasis.海马回避全脑放疗对非小细胞肺癌脑转移患者长期神经认知功能的保护作用。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211034269. doi: 10.1177/15330338211034269.
5
Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.使用调强弧形放疗对多发脑转移瘤进行海马区保护及同步整合加量的全脑放疗治疗计划策略
Med Dosim. 2016;41(4):315-322. doi: 10.1016/j.meddos.2016.08.001. Epub 2016 Sep 28.
6
Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking.全脑放射治疗同步整合增敏期间优化海马 sparing 及完全定向海马 block 的疗效。
Strahlenther Onkol. 2022 Jun;198(6):537-546. doi: 10.1007/s00066-022-01916-3. Epub 2022 Mar 31.
7
Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy.海马体保护全脑放疗:使用螺旋断层放疗和基于直线加速器的调强放疗的“操作方法”技术。
Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1244-52. doi: 10.1016/j.ijrobp.2010.01.039.
8
Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.海马剂量测定与全脑放疗期间海马保护后神经认知功能的变化相关:一项前瞻性研究。
Radiat Oncol. 2015 Dec 10;10:253. doi: 10.1186/s13014-015-0562-x.
9
Use of a Head-Tilting Baseplate During Tomotherapy to Shorten the Irradiation Time and Protect the Hippocampus and Lens in Hippocampal Sparing-Whole Brain Radiotherapy.在调强放疗中使用头倾基台缩短放疗时间并保护海马 spared 全脑放疗中的海马和晶状体
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033820986824. doi: 10.1177/1533033820986824.
10
Is Hippocampal Avoidance During Whole-Brain Radiotherapy Risky for Patients With Small-Cell Lung Cancer? Hippocampal Metastasis Rate and Associated Risk Factors.全脑放疗期间海马回避对小细胞肺癌患者有风险吗?海马转移率及相关危险因素。
Technol Cancer Res Treat. 2017 Dec;16(6):1202-1208. doi: 10.1177/1533034617742301. Epub 2017 Nov 21.

引用本文的文献

1
Venous thromboembolism risk factors in pediatric patients with high-grade glioma: a multicenter retrospective study.小儿高级别胶质瘤患者静脉血栓栓塞的危险因素:一项多中心回顾性研究
Front Pediatr. 2025 Aug 12;13:1595223. doi: 10.3389/fped.2025.1595223. eCollection 2025.
2
Neurocognitive outcome of HS-WBRT vs WBRT in patients with brain metastases: A systematic review and meta-analysis.脑转移瘤患者中高分割全脑放疗与全脑放疗的神经认知结局:一项系统评价与荟萃分析
Neurooncol Adv. 2025 May 30;7(1):vdaf073. doi: 10.1093/noajnl/vdaf073. eCollection 2025 Jan-Dec.